Literature DB >> 23735980

Clinical management of the extracorporeal membrane oxygenation circuit.

Warwick Butt1, Micheal Heard, Giles J Peek.   

Abstract

The clinical management of patients on extracorporeal membrane oxygenation should be standardized and follow clear guidelines or protocols. However, due to the diversity of cannulation strategies and the complex situations that extracorporeal membrane oxygenation is now used in, each extracorporeal membrane oxygenation program has developed its own clinical management strategies. These vary widely across the globe. Extracorporeal membrane oxygenation provides partial or complete support of ventilation and oxygenation, as well as univentricular or biventricular support of myocardial function, either individually or in combination. High-flow extracorporeal membrane oxygenation can also provide circulatory support in profound vasoplegic shock. Improvements in technology and greater understanding of disease pathophysiology, coupled to refinements in technology, which lessen the adverse interaction between the circuit and the patient, all contribute to fewer mechanical and patient complications on extracorporeal membrane oxygenation. Earlier and more appropriate use of extracorporeal membrane oxygenation has been associated with improved patient outcomes. These clinical management strategies are reviewed in this article, part of the Pediatric Cardiac Intensive Care Society/Extracorporeal Life Support Organization Joint Statement on Mechanical Circulatory Support.

Entities:  

Mesh:

Year:  2013        PMID: 23735980     DOI: 10.1097/PCC.0b013e318292ddc8

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  8 in total

1.  Vancomycin Dosing in Pediatric Extracorporeal Membrane Oxygenation: Potential Impacts of New Technologies.

Authors:  Kevin P Lonabaugh; Kelly J Lunsford; Gary Y Fang; David A Kaufman; Samuel D Addison; Marcia L Buck
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Sep-Oct

2.  Nosocomial Infections During Extracorporeal Membrane Oxygenation in Pediatric Patients: A Multicenter Retrospective Study.

Authors:  Chunle Wang; Shuanglei Li; Feng Wang; Jinfu Yang; Wei Yan; Xue Gao; Zhiqiang Wen; Yaoyao Xiong
Journal:  Front Pediatr       Date:  2022-06-13       Impact factor: 3.569

3.  Antibody-modified conduits for highly selective cytokine elimination from blood.

Authors:  J Brian McAlvin; Ryan G Wylie; Krithika Ramchander; Minh T Nguyen; Charles K Lok; Morgan Moroi; Andre Shomorony; Nikolay V Vasilyev; Patrick Armstrong; Jason Yang; Alexander M Lieber; Obiajulu S Okonkwo; Rohit Karnik; Daniel S Kohane
Journal:  JCI Insight       Date:  2018-07-12

4.  Extracorporeal membrane oxygenation line-associated complications: in vitro testing of cyanoacrylate tissue adhesive and securement devices to prevent infection and dislodgement.

Authors:  Taressa Bull; Amanda Corley; Danielle J Smyth; David J McMillan; Kimble R Dunster; John F Fraser
Journal:  Intensive Care Med Exp       Date:  2018-03-12

5.  In vitro testing of cyanoacrylate tissue adhesives and sutures for extracorporeal membrane oxygenation cannula securement.

Authors:  India Pearse; Amanda Corley; Nicole Bartnikowski; John F Fraser
Journal:  Intensive Care Med Exp       Date:  2021-01-04

6.  Concepts from paediatric extracorporeal membrane oxygenation for adult intensivists.

Authors:  Warwick Butt; Graeme MacLaren
Journal:  Ann Intensive Care       Date:  2016-03-03       Impact factor: 6.925

Review 7.  Hematologic concerns in extracorporeal membrane oxygenation.

Authors:  Jonathan Sniderman; Paul Monagle; Gail M Annich; Graeme MacLaren
Journal:  Res Pract Thromb Haemost       Date:  2020-05-15

8.  Cannula and circuit management in peripheral extracorporeal membrane oxygenation: An international survey of 45 countries.

Authors:  Taressa Bull; Amanda Corley; India Lye; Amy J Spooner; John F Fraser
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.